Cancer Biology and Signaling
As a member you will be connected with researchers across the cancer continuum, from basic science through public health, and across all UCSD schools, SDSU and La Jolla institute. Learn more about funding opportunities and other member resources today.
Recent Program Publications
Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer.
aPC/PAR1 confers endothelial anti-apoptotic activity via a discrete β-arrestin-2-mediated Sphk1-S1PR1-Akt signaling axis
Proceedings of the National Academy of Sciences of the United States of American
Rob Signer, PhD
Department of Medicine
Colleen McHugh, PhD
Department of Chemistry and Biochemistry
David Schlaepfer, PhD
Department of OBGYN and Reproductive Sciences
12-1pm on Zoom
CT2 Lecture Series
Training the next generation of leaders in cancer drug and diagnostics development
Mondays 12PM - 1PM VIA ZOOM
Development of an Individualized Neoantigen Cancer Vaccine
Speaker: Erza Cohen, M.D.
Comparative Effectiveness of Immune Checkpoint Inhibitors vs. Chemotherapy by Tumor Mutational Burden in Metastatic Prostate Cancer: Filling Evidence Gaps using Real-World Data
Speaker: Ryan Graf, PhD
Macrophage mediated antibody targeting of drug resistant solid tumors
Stephen McCormack, PhD, Alpha Beta Therapeutics
Zoom link: https://uchealth.zoom.us/j/81843764035?pwd=pdpFtTQTNsS2uY1NscOtjWYWS1mnep.1
The Cancer Biology and Signaling Program (CBS) conducts basic research on the biological processes that underlie normal cell growth regulation and the initiation and progression of cancer. Learn more about the program and goals here